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Reluctance to try novel tastes (neophobia) can be exacerbated in arousing situations,
such as when children are under social stress or in rodents, when the new taste is
presented in a high arousal context (HA) compared to a low arousal context (LA).
The present study aimed at determining whether adrenergic transmission at the Insula
regulates the reluctance to try novel tastes induced by arousing contexts. To this
end, a combination of systemic and intra-insular manipulations of adrenergic activity
was performed before the novel taste (saccharin 0.1%) was presented either in LA
or HA contexts in rats. Our results show that systemic adrenergic activity modulates
reluctance to try novel tastes. Moreover, intra-insular microinjections of propranolol
or norepinephrine (NE) were found to modulate the effects of arousing contexts on
reluctance to try novel tastes. Finally, intra-insular propranolol blocked epinephrine-
induced increased reluctance, while intra-insular NE blocked oral propranolol-induced
decreases in reluctance and increased the reluctance to try novel tastes presented in
low arousing contexts. In conclusion, our results suggest that the insula is a critical site
for regulating the effects of arousal in the reluctance to try novel tastes via the adrenergic
system.
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Introduction
Reluctance to novelty or Neophobia is a common adaptive behavior that ensures a cautious
response to a novel stimulus until its safety has been ascertained. In animals including
humans, consuming novel foods is usually accompanied by reluctance. For example, the
experience of social pressure to consume novel foods in children can induce dislike for those
foods (Batsell et al., 2002). The reluctance to try novel tastes was studied in the 60 s and
70 s when it was shown that domestic rats suffering from vitamin deficiency show strong
decreases in their reluctance to try novel tastes, believed to ease the transition from vitamin
deficient diets to novel ones (Rozin and Rodgers, 1967). Neophobia can be measured in a
laboratory setting when animals (e.g., rodents) are exposed to a novel taste by itself or as a
choice to water (Dunn and Everitt, 1988; Stehberg and Simon, 2011) and can be significantly
increased if the novel taste is presented after stress (Dess, 1992) or in a novel context (high
arousal context, HA) compared to a homecage (low arousal context, LA; De la Casa and Díaz, 2013).
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This type of behavioral response has been used to measure
anxiety in rodents. In fact, exposure to novel environments
induces avoidance to consume novel foods (food chow rather
than a particular taste dissolved in water) presented in those
environments, behavior known as hyponeophagia and used to
measure anxiety (Deacon, 2011).
Little is currently known about the brain areas and
mechanisms that determine the reluctance to try novel tastes
and how they are affected by stress and arousal. Lesion studies
suggest that taste neophobia is modulated by the taste area within
the Insular Cortex (or Insula, IC; Roman and Reilly, 2007; Lin
et al., 2009; Stehberg et al., 2011; Moraga-Amaro et al., 2014).
In the rat, the taste responsive area of the insula occupies the
dysgranular and granular subregions dorsal to the rhinal fissure,
from 1.5 mm posterior until 1.5 mm anterior to the Middle
Cerebral artery (Paxinos and Watson, 2007), identified as taste
responsive using intrinsic signal imaging (Accolla et al., 2007) as
well as electrophysiologically (Yamamoto et al., 1980; Kosar et al.,
1986; Ogawa et al., 1990; Bahar et al., 2004).
Although the neurotransmitters involved in the formation of
novel taste memory, familiar taste memory and conditioned taste
aversion have been studied in some detail (Berman et al., 2000;
Bermúdez-Rattoni et al., 2004; Guzmán-Ramos et al., 2012),
very few studies have attempted to study the neurotransmitters
involved in taste neophobia and in arousal-induced increases
in taste neophobia. This is probably due to the fact that the
reluctance to try novel tastes only lasts seconds to minutes, but
memories linger for days or even for a life time. Understanding
the cortical mechanisms by which stress and arousal affects
unconditioned spontaneous behaviors that depend directly on
cortex, such as the reluctance to try novel tastes, could pave the
way not only to the understanding of how stress directly affects
behavior, including how it affects our perception of novelty, but
may also lead to novel targets for the treatment of stress and
anxiety disorders.
Early studies suggest that hyponeophagia depends on an
intact brain norepinephrine system (Sahakian et al., 1983; Cole
et al., 1988). During acute stress or arousal, epinephrine (EPI)
is released by the adrenal medulla in response to an early
sympathetic response, activating indirectly the release of brain
norepinephrine (NE) from the locus coeruleus (McGaugh et al.,
1996). Brain NE in turn activates the hypothalamic-adrenal axis
(O’Connor et al., 2000), causes a shift from focused processing
of sensory information to general scanning of the environment
(Aston-Jones and Cohen, 2005; Roozendaal et al., 2009a;
Sara, 2009) and enhances memory consolidation of stressful
experiences (Liang et al., 1990; McGaugh and Roozendaal,
2002) in order to ensure a predictive or prompt response to
a similar stressful situation in the future. NE enhancement
of memory consolidation of emotionally arousing experiences
is modulated by glucocorticoids (Roozendaal et al., 2009b),
which have been shown to enhance memory in HA contexts or
concomitant to NE administration in LA contexts (Roozendaal
et al., 2006), suggesting that NE is capable of inducing high
arousal experiences during low arousal situations.
Here we aim at studying the role of the adrenergic system
at the insular cortex in modulating taste neophobia and
arousal-induced increases in the reluctance to try novel tastes, by
using a combination of systemic and intra-cortical manipulations
of adrenergic activity before the presentation of saccharin as a
novel taste, either at a LA (homecage) or HA context (lit novel
clean cage).
Experimental Procedures
All procedures involving animals were in accordance with the
U.S. National Institutes of Health guidelines and with approval
of the Bioethical Committee of the Universidad Andres Bello.
Male Sprague-Dawley rats (60 days old, 200–250 g) were caged
individually with free access to food and water at 22◦C, under
a 12-h light-dark cycle. The rats remained in their homecage
throughout the study and were removed only for surgery, and
briefly for drug administrations and behavioral procedures.
Surgical Procedures
Cannulas were chronically implanted as described previously
(Stehberg et al., 2012). In brief, animals were deeply anesthetized
with a combination of ketamine/xylazine (0.02 µl/kg and
0.33 µl/kg, respectively), placed in a stereotaxic apparatus
and their skull was surgically exposed after applying lidocaine
subcutaneously into the scalp (2% HCl). Animals were then
stereotaxically implanted bilaterally with a 21-gauge stainless
steel guide cannulae positioned at 1.0 mm above the IC
[1.2 mm anterior to Bregma, 5.4 mm lateral to the midline,
and 6.7 mm ventral to the skull surface (Paxinos and Watson,
1986)]. The cannula was fixed to the skull using acrylic dental
cement and secured by four screws. A stylus was placed inside
the guide cannula to prevent clogging. After surgery, animals
received a subcutaneous injection of ketoprofen 1% (Naxpet,
laboratorio Drag pharma Chile Invetec S.A., Chile, 3 mg/Kg) and
a dermal ointment consisting of a bacitracin/neomycin mixture
(Laboratorio Chile, subsidiary of TEVA in Chile) was applied
over the surgical area. Rats were given at least 7 days to recover
from surgery before beginning experimental procedures and
were handled for 10 min daily to habituate them to soft pressure
on the implant throughout the recovery period to decrease
microinfusion-related stress.
Intra-insular microinfusions were performed 10 min
before taste presentation to avoid any behavioral effects from
microinfusion discomfort. For microinfusion, the stylus was
removed and a 25-gauge injection cannula was inserted through
the guide cannula with its tip extending 1.0 mm beyond the guide
cannula tip, into the dysgranular area of the insula, believed
to be the taste responsive area according to previous literature
using electrophysiology (Yamamoto et al., 1980; Kosar et al.,
1986; Ogawa et al., 1990; Bahar et al., 2004) and intrinsic signal
imaging (Accolla et al., 2007). Drugs were microinfused via
the injection cannula, connected by PE20 tubing to Hamilton
micro-syringes driven by an electronic microinfusion pump.
Infusions consisted of 0.5 µl delivered at a rate of 0.25 ul/min to
each hemisphere. Following drug microinfusion, the injection
cannula was left in place for 3 min to allow the drug to diffuse
away from the tip. Cannula placement was later determined by
histology and maximal diffusion was verified by infusing 0.5 µl
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of India ink in a group of five rats. The maximal diffusion
spread observed included the caudal insular cortex (granular,
dysgranular and agranular areas) and in some cases the
claustrum, capsula externa, caudoputamen and somatosensory
secondary cortex.
To evaluate to which extent adrenergic activity in the insular
cortex modulates arousal-induced increases in the reluctance to
try novel tastes, a combination of systemic and intra-insular
manipulations of adrenergic activity were performed.
Drugs
All experimental groups were compared to a vehicle micro-
infused control group. For the first experiment, intra insular
propranolol (S(-)-Propranolol hydrochloride, Santa Cruz
Biotechnology Inc., Dallas, TX, USA) was administered into
the insular cortex at 1, 5 and 10 µg/0.5 µl dissolved in sterile
saline. In the second experiment, an intra-insular microinfusion
of 1 µg/0, 5 µl of NE (L-Norepinephrine hydrochloride, Sigma-
aldrich, St. Louis, MO, USA) was performed. For the third
experiment, systemic (oral) propranolol (Laboratorio Chile,
subsidiary of TEVA, Chile) was administered dissolved in tap
water for 1 h before taste presentation at a dose of 13.3 mg/kg,
combined with an intra-insular microinfusion of NE at a dose
of 1 µg/0.5 µl, 10 min prior to the neophobia test. For the
fourth experiment, systemic epinephrine ((±) Epinephrine
hydrochloride, Santa Cruz Biotechnology Inc., Dallas, TX, USA)
was dissolved in sterile saline and administered i.p. 30 min before
taste presentation using doses of 0.001, 0.01, 0.1 and 1 mg/kg.
In the last experiment, systemic epinephrine (0.1 mg/kg) was
followed by intra-insular microinjection of propranolol (1, 5 and
10 µg/0.5 µl).
Behavioral Testing
Rats underwent water restriction during behavioral procedures.
On the training phase (day 1 to day 3), animals were trained
to drink from two pipettes of 10 ml each and allowed to drink
their daily fluid intake within a 10 min interval per day, for
three consecutive days before the test. On the experimental day
animals were randomly assigned to different groups and were
exposed to saccharin 0.1% as the novel taste according to the
method used in Stehberg and Simon (2011). In brief, 10 min
long presentations of the taste (saccharin 0.1% dissolved in water)
as a choice to water (taste presentation; six pipettes containing
5 ml each alternating taste or water). Free choice tests were
used and preferred over one or two bottle tests to force rats
to choose and drink from at least three pipettes to meet their
daily needs of fluid intake (for a discussion on the benefits of
using free choice tests see (Moraga-Amaro et al., 2014). During
the test, animals were offered six pipettes of 5 ml each, with a
total of 30 ml so that animals are exposed to a choice of the
novel taste (saccharin) and water, but are not forced to drink
from either. Thus, by giving them 30 ml to choose from, the
animal will not be forced to drink from all the pipettes to quench
its thirst, but may instead choose to drink up to 15 ml of any
of the two tastes without needing to drink more than 5 ml of
the other. This way, the animal is forced to choose and to try
both tastes, but not forced to drink from any particular taste. To
elicit the least neophobic response, the novel taste was presented
in the LA context which was the animal’s homecage. To elicit
the greatest neophobic response a HA context was used, which
consisted of a brightly illuminated (100 lux) clean cage void of
wood shavings. Animals were put into the HA context 3 min
before taste presentation and were monitored for any unusual
behavior. Novel taste consumption was measured as aversion
index, which represents the percentage of avoidance of the taste
and is measured as the amount of water consumed divided by
total liquid consumption.
Histology
At the end of all experiments, animals were anesthetized as
above and perfused intracardially with saline and 4% buffered
paraformaldehyde. Brains were extracted and left afloat in 30%
sucrose until its density equaled that of sucrose. The brains
were sectioned in a cryostat, Nissl-stained (cresyl violet) and
examined using light microscopy for cannula placement and
assessment of histological lesions, defined by tissue damage
and/or gliosis. Animals with injection cannula tip outside the
insular cortex or showing histological lesions beyond the size of
the cannula tip and guide cannula diameter were excluded from
the analysis.
Statistics
Data are expressed as mean ± standard error (SE). All
experimental groups were tested for normality using the
Kolmogorov-Smirnov test. Given that all data sets were found to
be normally distributed, an unpaired Student’s t test was used
when comparing two different groups and considered significant
at values of p < 0.05. For multiple comparisons, a One-way
ANOVA with Bonferroni post hoc tests was used, considering α
significance level of p< 0.05.
Results
Animals that showed a lesion larger than the size of the injection
cannula or whose injection site was not located within the
dysgranular or granular zones of the Insular cortex as described
by Cechetto and Saper (1987) were excluded from analysis.
For a scheme of the cannula locations included in the analysis
see Figure 1A and for a representative microphotograph of a
successful implant see Figure 1B.
As can be seen in Figure 2A (open bar), presentation of the
novel taste in a LA context induced reluctance to consume the
novel taste (neophobia), which is reflected by a slight aversion
to the taste (drinking lower amounts of the taste compared
to water) reaching 60% ± 3.6 aversion, which is greater than
chance drinking (50%) or preferred drinking (any value <50%).
However, when the novel taste is presented in a HA context,
taste aversion increases significantly to 75%± 4.5, which reflects
what is here considered as arousal-induced increase in taste
neophobia (see Figure 2A, closed bar; N = 10 each; p < 0.05).
To ease viewing, in all graphs except for those showing total
fluid intake, experiments performed in HA contexts are shown
with closed bars, while those performed in LA contexts, with
open bars.
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FIGURE 1 | Location of cannula implants within the insular cortex.
(A) Scheme of a brain coronal section showing the dysgranular (gustatory)
area of the insular cortex, which was targeted by cannula implants.
(B) Microphotograph of a representative cannula implant into the dysgranular
(taste) area of the insular cortex. Scale bar: 1 mm.
In the first experiment we aimed at testing whether adrenergic
activity in the insula modulates arousal-induced increases in
neophobia. For this aim propranolol was microinjected into the
insular cortex prior to taste presentation in a HA context. As
can be seen in Figure 2B, 5 µg of intra-insular propranolol
produced a significant decrease in the reluctance to try the novel
taste, suggesting that adrenergic activity at the insular cortex
modulates arousal-induced increases in taste neophobia (for a
curve-response graph see Figure 2B; Veh: 67 ± 5.3%, 1 µg:
56± 4.2% (p< 0.05), 5 µg: 48± 4.1%; 10 µg: 59± 4.5%; n = 12,
10, 10, 10 respectively).
To test if brain NE at the insular cortex can increase the
reluctance to try novel tastes when the taste is presented in a
LA context, in a manner similar to the arousal-induced increases
in taste neophobia obtained when the taste is presented in a
HA context, dose response curve of NE was microinjected into
the Insular cortex, in a LA context (Exp. 2). As can be seen
in Figure 2C, a significant increase in reluctance was obtained
when microinjecting 1 µg of NE into the insula (for a dose-
response curve see Figure 2C; veh: 58 ± 1.9%, 1 µg: 69 ± 2.6%
(p < 0.01), 10 µg: 60 ± 1.9%, 100 µg: 62 ± 2.7%, n = 15, 11, 11,
13 respectively).
To test if the systemic effects of propranolol can be blocked
by NE at the insular cortex, propranolol was administered
orally (13.3 mg/kg) and 1 µg of NE was microinjected into
FIGURE 2 | The adrenergic antagonism by propranolol in
arousal-induced taste neophobia and its modulation by the
insular cortex. (A) Comparison of the neophobic response to a new
taste (saccharin 0.1%) when it is presented in a low arousal context
(LA) (open bar) compared to a high arousal context (HA) (closed bar).
Note that arousal induces increases in taste neophobia (N = 10
each, *p < 0.05). (B) Dose-response curve for Intra-insular
propranolol in arousal-induced neophobia (taste presented in a HA
context). Note that the 5 µg induced a significant decrease in
arousal-induced neophobia (N = 12, 10, 10, 10; *p < 0.05). (C)
Dose response curve of Intra-insular norepinephrine in
arousal-induced neophobia when taste is presented in a LA context.
Note that 1µg induced a significant increase in neophobia. (N = 15,
11, 11, 13; **p < 0.001) (D) Inhibition of the effects of 5 µg oral
propranolol by intra-insular norepinephrine. Oral propranolol (Prop +
Veh) induced a significant decrease in arousal-induced taste
neophobia compared to Vehicle injected controls (Veh Prop-Veh NA),
effect that was blocked when oral propranolol was followed by 5 µg
of intra-insular norepinephrine (Prop + NA; N = 11, 10, 7; *p < 0.05;
**p < 0.01; ***p < 0.001).
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the insular cortex, in a HA context. A significant decrease in
neophobia was found after propranolol was administered orally
(see Figure 2D, Prop + Veh NE), effect that was blocked when
oral propranolol was administered together with intra-insular
NE (see Figure 2D; Veh prop + Veh NE: 64 ± 2.1, Prop + Veh
NE: 52 ± 3.7 (p < 0.05), Prop + NE: 58 ± 5.2; N = 11, 10 and 7
respectively).
To test whether systemic adrenergic activity may affect
taste neophobia, epinephrine was administered systemically
in a LA context. Systemic administration of 0.1 mg/Kg
epinephrine induced a statistically significant increase
in neophobia to the taste, compared to vehicle injected
controls (Figure 3A; Veh: 64 ± 2.8%, 0.001 mg/Kg:
62 ± 4.3%, 0.01 mg/Kg: 82 ± 3.3%; 0.1 mg/Kg: 86 ± 3.8%
(p < 0.01); 1 mg/Kg: 69 ± 5.6%; n = 9, 10, 9, 10, 10
respectively). The 0.1 mg/kg dose had also significant
differences from the 0.001 mg/Kg (p < 0.01) and 1 mg/Kg
(p < 0.05) doses, while the dose of 0.01 mg/Kg showed a
statistically significant difference with the 0.001 mg/kg dose
(p< 0.05).
To determine whether the increase in reluctance to try
novel tastes induced by systemic epinephrine is mediated by
brain NE at the insular cortex, propranolol was microinjected
into the insular cortex before taste presentation in a LA
context with prior systemic injection of epinephrine. The
vehicle injected group showed low neophobia as expected from
a LA context (veh epi+veh prop), which was significantly
increased in response to systemic epinephrine (epinephrine +
Veh Prop; p < 0.05). All doses of intra-insular propranolol
induced a significant decrease in neophobia, reaching chance
drinking levels and blocking completely the effects of systemic
epinephrine (for a dose-response curve see Figure 3B; Veh
Epi + Veh Prop: 61 ± 1.6%, Epi + Veh Prop: 70 ± 2.9%
(compared to veh; p < 0.05); Epi + Prop 1 µg: 48 ± 2.7%
(compared to epi+veh prop; p < 0.001), Epi + Prop 5 µg:
54 ± 2.7% (compared to epi+veh prop; p < 0.01); Epi + Prop
10 µg: 55 ± 5.5% (compared to epi+veh prop; p < 0.05);
n = 14, 8, 7, 8, 7 respectively). For a summary of results see
Table 1.
To ensure that the drugs used did not affect the capacity
of animals to drink or their thirst, total liquid intake (water +
saccharin) was measured and compared between groups, for
every experiment. No significant differences were found in total
liquid intake between groups in the HA vs. LA neophobia
experiment (HA = 10 ± 0.7; LA = 12 ± 0.8; p > 0.05; Figure 3C
upper left), Propranolol dose response (Veh = 10 ± 0.7;
1 µg = 12 ± 0.9; 5 µg = 10 ± 1.0; 10 µg = 12 ± 1.2; p >
0.05; Figure 3C upper center), the systemic Propranolol and
intra-insular NE experiment (Veh Prop + Veh NE = 10 ± 0.6;
Prop + Veh NE = 10 ± 0.7; Prop + NE = 8 ± 0.9, p >
0.05; Figure 3C lower left), or the epinephrine and intra-insular
propranolol experiment (Veh Epi + Veh Prop = 12 ± 0.6; Epi
+ Veh Prop = 13 ± 1.0; Epi + Prop 1 µg = 13 ± 1.2; Epi + Prop
5µg = 13± 0.8; Epi + Prop 10µg = 14± 1.1, p> 0.05; Figure 3C
lower right). There were non-significant differences in total
fluid intake after intra-insular NE injections (Veh = 12 ± 0.4;
1 µg = 14 ± 0.7; 10 µg = 13 ± 0.6; 100 µg = 11 ± 1.1;
p > 0.05; Figure 3C upper right) and also non-significant
differences in total fluid intake after systemic epinephrine
(veh = 12 ± 0.6; 0.001 mg = 11 ± 0.8; 0.01 mg = 9 ± 0.9;
0.1 mg = 9 ± 1.0; 1 mg = 10 ± 1.0; p > 0.05; Figure 3C lower
center).
TABLE 1 | Summary of results.
Figure Experiment N Groups AI (%) p value
2A HA vs. LA 10 HA 60 ± 3.6
10 LA 75 ± 4.5 *0.0193
2B intra-insular Propanolol dose response curve (HA) 12 Veh 67 ± 5.3
10 1 µg 56 ± 4.2
10 5 µg 48 ± 4.1 *0.0470
10 10 µg 59 ± 4.5
2C Intra-insular Noradrenaline dose response curve (LA) 15 Veh 58 ± 2.6
11 1 µg 69 ± 2.6 **0.0082
11 10 µg 60 ± 1.9
13 100 µg 62 ± 2.7
2D Inhibition of oral Propanolol by intra-insular Noradrenline (HA) 11 Veh prop + Veh NA 64 ± 2.1
10 Prop + Veh NA 52 ± 3.7 *0.0470
7 Prop + NA 58 ± 5.2
3A Systemic Epinephrine dose response curve (LA) 9 Veh 64 ± 2.8
10 0.001 mg 62 ± 4.3
9 0.01 mg 82 ± 3.3
10 0.1 mg 86 ± 3.8 ***0.0002
10 1 mg 69 ± 5.6
3B Epinephrine (0.1 mg) + intra-insular Propanolol dose response curve (LA) 8 Epi + Veh prop 70 ± 3.8
7 Epi + Prop 1 µg 48 ± 2.7 **0.0022
8 Epi + Prop 5 µg 54 ± 2.7
7 Epi + Prop 10 µg 55 ± 5.5
Depicted from left to right are: the Figure panel where experiment is shown (Figure), a description of the experiment (Experiment), the number of animals per group (N),
the groups compared (Groups), the aversion index obtained (AI%) and the P value if significant (*if p < 0.05; **if p < 0.01; ***if p < 0.001).
Frontiers in Behavioral Neuroscience | www.frontiersin.org 5 June 2015 | Volume 9 | Article 164
Rojas et al. Insular adrenergic transmission modulates neophobia
FIGURE 3 | Effects of systemic epinephrine in neophobia and its
modulation by the insular cortex. (A) Dose response curve of
systemic epinephrine in a LA context. Note that 0.1 mg of epinephrine
induced a significant increase in taste neophobia (N = 9, 10, 9, 10, 10;
***p < 0.001) when the novel taste was presented in a LA context.
(B) Dose response of intra-insular propranolol after a systemic
epinephrine when novel taste is presented in a LA context. Note that
1µg of intra-insular propranolol (Epi + Prop 1µg) blocked the increase in
neophobia induced by 0.1 mg of systemic epinephrine (Epi + Veh Prop;
(N = 8, 7, 8, 7; **p < 0.01). (C) Injections did not induce significant
changes in total liquid consumption. Experiments in LA are shown in
open bars, experiments performed in HA are shown in closed bars.
Upper-middle: propranolol; left-upper right; noradrenaline; center-bottom:
epinephrine. *p < 0.05; **p < 0.01; ***p < 0.001.
Discussion
A summary of the experiments and results of this study can
be found in Table 1. The present results suggest first, that
adrenergic activity modulates the effects of arousal in taste
neophobia, as systemic propranolol can reduce arousal-induced
increases in neophobia (in a HA context), while epinephrine
can increase neophobia in a LA context. Secondly, our results
show that adrenergic activity at the insular cortex modulates
arousal-induced increases in neophobia. This conclusion is
supported by the fact that intra insular propranolol decreased
reluctance to try novel tastes in HA contexts, while intra
insular NE increased neophobia in a LA context. Both arousal-
induced and epinephrine-induced increases in neophobia can
be blocked by intra-insular propranolol, which may suggest that
systemic adrenergic activity may be involved in arousal-induced
increases in neophobia and that adrenergic activity at the insula
may modulate this effect. This idea was further supported by
the fact that intra-insular microinjections of NE produced an
increase in taste neophobia when the taste is presented in LA
contexts.
Evidence for a role of brain NE in food neophobia (or
hyponeophagia) comes from studies showing that chemical NE
depletion induces increased consumption of novel vs. familiar
rat chow in novel contexts using 6-hydroxydopamine lesions
of the noradrenergic bundle (Sahakian et al., 1983; Cole et al.,
1988) or the olfactory bulb (Royet et al., 1983). Moreover,
centrally acting propranolol and pindolol but not atenolol were
able to decrease hyponeophagia (Shephard et al., 1982), while
microinjections of NE into the basolateral amygdala induced
an increase in food neophobia (Borsini and Rolls, 1984),
suggesting that the Basolateral amygdala may also be involved
in food neophobia. The amygdala shares several functions
with the insular cortex and both interact extensively (Moraga-
Amaro and Stehberg, 2012). In a study of Lin and Reilly (Lin
and Reilly, 2012) using a combination of unilateral lesions
of the insular cortex and amygdala, showed that Amygdala-
gustatory insular cortex connections are necessary for taste
neophobia.
From the present results it is possible to propose that
during arousal, sympathetic activity will lead to the release of
adrenal epinephrine, which in turn will trigger the release of
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brain NE (McGaugh et al., 1996). Brain NE will be released
at the insular cortex, triggering an increase in reluctance
to try novel tastes. There may be other neurotransmitters,
neuromodulatory systems and brain areas involved in
this process, which have not been studied in the present
report.
Distinguishing a role for adrenergic activity in neophobia per
se, from arousal-induced increases in neophobia is challenging.
When a taste is presented in the LA context (namely, the animal’s
homecage) the experience itself is—as the name implies—of ‘‘low
arousal’’, not of ‘‘no arousal’’. This means that the decrease in
neophobia induced by propranolol when the taste is presented
in a LA context may reflect a role for the adrenergic system in
neophobia per se, but may also reflect an effect of propranolol
on the arousal—despite being low—that the presentation of the
novel taste may induce.
In a study published by Roozendaal and Cools (1994), Wistar
rats were placed in an openfield and divided according to their
exploratory behavior (less or more than 8 min to habituate
and 48 meters locomotion per 30 min) into high and low
responders. Then they were microinjected into the basolateral
amygdala with either beta-adrenergic antagonist propranolol or
beta-adrenergic agonist isoproterenol and 5 min later presented
with a choice of novel and familiar chow in a HA context.
Interestingly, propranolol reduced food neophobia only in the
high responders, while isoproterenol decreased food neophobia
only in low responders (Roozendaal and Cools, 1994). This
suggests that the effects of adrenergic manipulations may depend
on the animals’ responsiveness to stress or basal levels of anxiety.
It remains to be determined whether this holds true for the insula
adrenergic manipulations, or it may be unique to amygdala. If
so, it may help distinguishing a role for the amygdala associating
the taste response with the basal level of anxiety of each animal.
In the present study no screening tests were performed to
distinguish responders. More studies are required to assess this
issue.
As can be seen in Figure 3C, the different injections did not
interfere with the animals’ capacity to drink or their thirst. This
is important, as is widely known that exposure to novel contexts
induces anxiety, while adrenergic activity also mediates anxiety
(Nesse et al., 1984). Thus, here we show that the change in anxiety
by contexts or drugs used affected the rats’ preference for the
novel taste, but not their capacity to drink or their overall thirst.
In conclusion, here we show that the adrenergic system
modulates the effects of arousing contexts in the reluctance to
try novel tastes via the insular cortex, suggesting that the insula
may be a cortical site critical for modulating the effects of arousal
in gustatory behavior. Given that hyponeophagia is used as a
measure of anxiety, further studies are required to determine
whether the role of the insular cortex may go beyond taste
reluctance and modulate stress and anxiety.
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